Compounds for treatment of cancer
US8592465B2 · kind B2 · utility
3Cited by
3References
32Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 16, 2009 |
| Grant date | Nov 26, 2013 |
| Priority date | — |
| Expiry date | Jul 6, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds according to formula (I) are disclosedwhere Q is S, N, or O; X is optional, and can be O═, S═, ═N—NH2, ═N—OH, or —OH; Y is optional and can be —N(H)—, O, or C1 to C20 hydrocarbon; and R1 and R2 are each independently substituted or unsubstituted single-, fused- or multiple-ring aryl or (hetero)cyclic ring systems. Methods of making these compounds, pharmaceutical compositions containing the compounds, and their use, particularly for treating or preventing cancer, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.